Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect
Dvorák, K.; Vavros, B.; Cerný, J.
Vnitrni Lekarstvi 21(3): 278-284
1975
ISSN/ISBN: 0042-773X PMID: 47209 Document Number: 92919
Document emailed within 1 workday
Related Documents
Borkowski, P.J. 1970: Bretylium tosylate as an antiarrhythmic agent Kardiologia Polska 13(2): 195-198Steffen, V.; Assmann, I.; Fiehring, H. 1976: Clinical experiences with bretylium tosylate Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(17): 684-688
Szulc, E.J. 1971: Value of bretylium tosylate in controlling arrhythmia Wiadomosci Lekarskie 24(18): 1783-1785
Lee, Y.C.; Malick, A.W.; Amann, A.H.; Baaske, D.M.; Shah, J.J.; Wagenknecht, D.M.; Carter, J.E. 1981: Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin American Journal of Hospital Pharmacy 38(2): 183-187
Dhurandhar, R.W.; Pickron, J.; Goldman, A.M. 1980: Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction Heart and Lung: the Journal of Critical Care 9(2): 265-270
Kaverina, N.V.; Chichkanov, G.G.; Tsorin, I.B.; Kirsanova, G.Iu. 2004: Activation of the sympathetic nervous system influences the antifibrillatory effect of class I antiarrhythmic drugs Eksperimental'naia i Klinicheskaia Farmakologiia 67(5): 17-18
Saini, R.K.; Antonaccio, M.J. 1982: Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 221(1): 29-36
Lynch, J.; Montgomery, D.; Ventura, A.; Wilber, D.; Lucchesi, B.R. 1986: Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride Arzneimittel-Forschung 36(3): 475-481
Parker, T.S.; Macri, J.R.; Jenden, D.J. 1976: A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine) Proceedings of the Western Pharmacology Society 19: 79-86
Beck, O.A.; Witt, E.; Hochrein, H. 1975: Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography Zeitschrift für Kardiologie 64(2): 179-187
Haas, H.G.; Kern, R.; Lack, E.G. 1971: The voltage-clamp technique as a tool for testing drugs: the antifibrillatory action of a neuroleptic agent (Droperidol) Arztliche Forschung 25(4): 110-125
Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Shargorodskii, B.M.; Kats, I.A. 1973: The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply Kardiologiia 13(3): 81-87
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R. 1985: Propafenone--a new antiarrhythmic agent. Clinical experience Casopis Lekaru Ceskych 124(13): 407-410
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Gülker, H.; Thale, J.; Olbing, B.; Heuer, H.; Frenking, B.; Bender, F. 1985: Assessment of the antiarrhythmic profile of the new class i agent diprafenone Arzneimittel-Forschung 35(9): 1387-1393
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697
Jacque, M. 1975: Effect of some antifibrillatory agents on the isolated rabbit auricle under hypothermia Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(1): 145-147
Karapetian, A.E.; Gevorkian, R.A. 1972: Action of 4-methyluracil as an antiarrhythmic agent stimulating the growth of myocardial cells Farmakologiia i Toksikologiia 35(3): 297-299
Valkó, I.; Szepesi, G. 1990: An improved TLC method for investigation of the metabolic profile of BGYKI-38233--a new antiarrhythmic agent Die Pharmazie 45(4): 290